Latest News

Hawkins stock at a glance Hawkins (HWKN) has drawn fresh attention after recent share price moves, including a month return above 14% and a slight negative shift over the past 3 months, prompting investors to reassess its current valuation. See our latest analysis for Hawkins. The recent 14.2% 1 month share price return and 3.99% year to date share price return suggest momentum has picked up again. The 26.6% 1 year total shareholder return and very large 3 and 5 year total shareholder returns...

Readers hoping to buy FastPartner AB (publ) ( STO:FPAR A ) for its dividend will need to make their move shortly, as...

International Paper stock in focus International Paper (IP) has drawn fresh attention after recent share price moves, with the stock showing a gain of about 10% over the past month and a decline of around 11% over the past 3 months. See our latest analysis for International Paper. The recent 9.98% 1-month share price return contrasts with a 10.87% 3-month share price decline and a 14.11% 1-year total shareholder return loss, which together indicate that short-term momentum has improved...

Duke Energy (DUK) has drawn fresh attention after committing over $850,000 to workforce training and community grants across its six-state footprint, just as investors look ahead to its upcoming fiscal first quarter earnings update. See our latest analysis for Duke Energy. The recent community and workforce investments come at a time when Duke Energy’s share price has shown steadier momentum, with a 90 day share price return of 7.09% and a 3 year total shareholder return of 45.52%. If you are...

Old National Bancorp recently reorganized its commercial banking leadership, appointing Chris Doyle as President of Commercial Banking and John C. Thurston as President of Corporate Banking, while more closely aligning Treasury, FX, FinTech, and service delivery functions to better serve increasingly complex clients. This leadership reshaping concentrates experienced bankers and operational leaders over C&I, corporate, capital markets, and treasury services, potentially sharpening execution...

In recent weeks, Becton, Dickinson and Company has highlighted new clinical data for its PureWick Urine Collection System, launched the HemoSphere Stream Module for continuous noninvasive blood pressure monitoring, advanced its Liverty TIPS Stent Graft program in portal hypertension, and received multi-category supply chain resilience awards from the Healthcare Industry Resilience Collaborative. Taken together, these developments underline BD’s push into higher-value, clinically...

The European market has recently seen positive momentum, with the pan-European STOXX Europe 600 Index rising as investors digest corporate earnings and geopolitical tensions ease. Amid these developments, penny stocks—an older term for smaller or newer companies—continue to attract attention due to their potential for growth and value. By focusing on those with strong financials and clear growth paths, investors can explore opportunities that might offer both stability and upside in the...

In April 2026, Veolia launched in London its Data Center Resource 360 global offer, aiming to turn data centers into carbon-neutral, water-positive, circular hubs by integrating water, waste, and energy management with real-time digital monitoring. This move positions Veolia to address rising environmental constraints on fast-growing digital infrastructure by offering an all-in-one solution to help data centers meet tightening resource, emissions, and permitting requirements in key markets...

Earlier in April 2026, Nutanix unveiled a broad set of AI- and cloud-focused product updates, including its Agentic AI stack, NKP Metal for bare‑metal Kubernetes, expanded multitenant cloud tools for service providers, and deeper integrations with partners such as NetApp, Nerdio, MongoDB, Cisco, Dell, and Lenovo, alongside a US$50.00 million increase to its share repurchase authorization to US$750.00 million. By tying together AI infrastructure, hybrid multicloud operations, service provider...

In April 2026, Compeer Financial reported that upgrading its lending operations to the FICO Platform has enabled faster, more accurate credit decisions across over US$10 billion in automated lending application throughput, with automation now supporting loans up to US$5 million. The implementation has created a fully automated, end-to-end decisioning ecosystem that cuts roughly 800 underwriter hours each month and lifts automated processing to 95% for smaller loans while materially...

As European markets navigate a landscape of cautious optimism amid geopolitical developments and economic adjustments, the STOXX Europe 600 Index has shown resilience with a notable uptick, driven by corporate earnings and easing tensions in the Middle East. In this environment, identifying promising small-cap stocks requires a keen understanding of market dynamics and potential growth drivers that align with broader economic indicators.

As European markets experience a positive uptick with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and stable economic indicators, investors are increasingly focused on dividend stocks as a means to generate steady income in an uncertain economic environment. In this context, identifying robust dividend-paying companies with strong fundamentals can be an effective strategy for those looking to balance growth potential with income generation.

It looks like Heba Fastighets AB (publ) ( STO:HEBA B ) is about to go ex-dividend in the next 3 days. Typically, the...

Investment AB Öresund (publ) ( STO:ORES ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is...

We feel now is a pretty good time to analyse Annexin Pharmaceuticals AB (publ)'s ( STO:ANNX ) business as it appears...

It looks like RSL Electronics Ltd. ( TLV:RSEL ) is about to go ex-dividend in the next two days. The ex-dividend date...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The market for Enel SpA's ( BIT:ENEL ) shares didn't move much after it posted weak earnings recently. We did some...

Anyone interested in Sun International Limited ( JSE:SUI ) should probably be aware that the CFO & Executive Director...

Recent share performance and business scale TotalEnergies (ENXTPA:TTE) has drawn attention after a recent 1 day return of around 5% decline and a 7 day return of about 8% decline, following a month return close to 5% decline. Despite this short term weakness, the stock shows a past 3 months return of about 28% and a 1 year total return near 50%, supported by a value score of 4 and a market cap around €155.8b. The group runs an integrated energy model across oil, biofuels, natural gas, biogas,...

Takeuchi Mfg (TSE:6432) has drawn fresh attention after reporting full year results to February 2026, issuing fiscal 2027 guidance, and outlining a new dividend framework that introduces interim payments alongside its existing year end dividend. See our latest analysis for Takeuchi Mfg. Despite the recent announcement of full year results, new guidance and a refreshed dividend framework, the share price has cooled in the very short term. The 7 day share price return is 7.40% and the 1 month...

Ichigo (TSE:2337) just paired its 2026 earnings call with fresh guidance for the year ending February 28, 2027, including detailed profit targets, higher dividend expectations, and an update on its changing J.League partnerships. See our latest analysis for Ichigo. The recent guidance and dividend update come as Ichigo shares trade at ¥514, with a 90 day share price return of 15.77% and a 1 year total shareholder return of 37.53%, suggesting momentum has been building around its earnings and...

Swedish Orphan Biovitrum (Sobi) and partner Apellis Pharmaceuticals have received Health Canada approval for EMPAVELI (pegcetacoplan) to treat rare kidney diseases C3 glomerulopathy and primary IC-MPGN in patients aged 12 and older, based on Phase 3 VALIANT data showing reduced proteinuria, stabilized kidney function, and clearance of C3 deposits. This decision extends EMPAVELI’s nephrology footprint beyond the US and EU into Canada, adding another rare-disease indication to Sobi’s portfolio...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...